Long-Term Adherence to IFN Beta-1a Treatment when Using RebiSmart® Device in Patients with Relapsing-Remitting Multiple Sclerosis

The effectiveness of disease-modifying drugs in the treatment of multiple sclerosis is associated with adherence. RebiSmart(®) electronic device provides useful information about adherence to the treatment with subcutaneous (sc) interferon (IFN) β-1a (Rebif(®)). The aim of the study was to determine...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Fernández, O., Arroyo, R., Martínez-Yélamos, S., Marco, M., Merino, J. A. García, Muñoz, D., Merino, E., Roque, A.
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2016
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4985132/
https://ncbi.nlm.nih.gov/pubmed/27526201
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0160313
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados